Roche Holding | GJELD

Debt Endring Dato
AbbVie USD 74B 13.26B 2024-03
Alcon AG USD 5.09B 49M 2024-03
Almirall EUR 352.3M 50.95M 2024-03
Amgen USD 64.02B 593M 2024-03
AstraZeneca USD 34.55B 5.93B 2024-03
Bayer EUR 45.01B 2.42B 2023-12
Biogen USD 6.95B 8.4M 2024-03
Bristol-Myers Squibb USD 57.41B 17.64B 2024-03
Eli Lilly USD 26.21B 6.04B 2024-03
Fresenius EUR 14.5B 3.32B 2024-03
Fresenius Medical Care EUR 12.03B 943.85M 2024-03
Galapagos EUR 7.98M 1.62M 2024-03
Genmab DKK 1.01B 240M 2024-03
Gilead Sciences USD 25.19B 212M 2024-03
GlaxoSmithKline GBP 17.77B 246M 2024-03
GRIFOLS EUR 10.12B 939.25M 2023-12
Hikma Pharmaceutical USD 1.19B 121M 2023-12
Lonza CHF 2.8B 109M 2023-12
Merck EUR 9.95B 13M 2024-03
Merck USD 34.22B 640M 2024-03
Novartis USD 27.28B 936M 2024-03
Orion EUR 194.6M 5.4M 2024-03
Pfizer USD 68.71B 5.11B 2024-03
Philips EUR 7.69B 472M 2023-12
Recordati EUR 1.73B 81.66M 2024-03
Regeneron Pharmaceuticals USD 2.7B 400K 2024-03
Roche Holding CHF 29.21B 3.82B 2023-12
UCB EUR 3.04B 142M 2023-12



Roche Holding GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.